Background: To develop and validate a multivariable risk prediction model for ketosis-prone type 2 diabetes mellitus (T2DM) based on clinical characteristics.
Methods: A total of 964 participants newly diagnosed with T2DM were enrolled in the modeling and validation cohort. Baseline clinical data were collected and analyzed. Multivariable logistic regression analysis was performed to select independent risk factors, develop the prediction model, and construct the nomogram. The model's reliability and validity were checked using the receiver operating characteristic curve and the calibration curve.
Results: A high morbidity of ketosis-prone T2DM was observed (20.2%), who presented as lower age and fasting C-peptide, and higher free fatty acids, glycated hemoglobin A1c and urinary protein. Based on these five independent influence factors, we developed a risk prediction model for ketosis-prone T2DM and constructed the nomogram. Areas under the curve of the modeling and validation cohorts were 0.806 (95% confidence interval [CI]: 0.760-0.851) and 0.856 (95% CI: 0.803-0.908). The calibration curves that were both internally and externally checked indicated that the projected results were reasonably close to the actual values.
Conclusions: Our study provided an effective clinical risk prediction model for ketosis-prone T2DM, which could help for precise classification and management.
背景:基于临床特征构建酮症倾向2型糖尿病(T2DM)的多变量风险预测模型并进行验证。 方法:共有964名新诊断为T2DM的参与者被纳入建模和验证队列, 收集并分析基线临床资料。采用多变量logistic回归分析, 筛选独立危险因素, 建立预测模型并构建模态图。利用受试者特征曲线和标定曲线对模型的信度和效度进行检验。 结果:酮症倾向T2DM患病率较高(20.2%)。酮症倾向的T2DM患者年龄, 空腹C肽水平较低, 游离脂肪酸, 糖化血红蛋白和尿蛋白水平较高。基于这5个独立影响因素, 构建酮症倾向T2DM的风险预测模型并构建列线图。建模队列和验证队列的曲线下面积分别为0.806(95%可信区间:0.760 ~ 0.851)和0.856(95%可信区间:0.803 ~ 0.908)。内部和外部校准曲线表明, 预测结果与实际值相当接近。 结论:本研究为酮症倾向T2DM患者提供了一种有效的临床风险预测模型, 有助于对酮症倾向T2DM患者进行精准分类和管理。.
Keywords: clinical characteristic; ketosis-prone type 2 diabetes mellitus; nomogram; prediction model; 临床特征; 列线图; 酮症倾向2型糖尿病; 预测模型.
© 2023 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.